Published in J Immunol on May 01, 1981
Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest (1983) 2.32
Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus. J Virol (1986) 1.85
Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation (1988) 1.61
Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression. J Virol (1988) 1.57
Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood. J Virol (1987) 1.20
Molecular biology and immunology of cytomegalovirus. Biochem J (1987) 1.19
Rapid degradation of the heavy chain of class I major histocompatibility complex antigens in the endoplasmic reticulum of human cytomegalovirus-infected cells. J Virol (1994) 1.12
Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus. Proc Natl Acad Sci U S A (1986) 1.09
Priming of immature thymocytes to CD3-mediated apoptosis by infection with murine cytomegalovirus. J Virol (1994) 1.07
Killing of measles virus-infected cells by human cytotoxic T cells. Infect Immun (1982) 1.06
Cytomegalovirus-specific cytotoxicity mediated by non-T lymphocytes from peripheral blood of normal volunteers. Infect Immun (1981) 1.03
Enhancive and suppressive effects of cytomegalovirus on human lymphocyte responses in vitro. J Virol (1986) 0.97
Use of bone marrow fibroblasts to prepare targets for an HLA restricted-cytotoxicity assay system. J Clin Microbiol (1984) 0.97
The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation (1993) 0.95
Effect of several antiviral agents on human lymphocyte functions and marrow progenitor cell proliferation. Antimicrob Agents Chemother (1983) 0.92
Lysis of varicella zoster virus infected cells by lymphocytes from normal humans and immunosuppressed pediatric leukaemic patients. Clin Exp Immunol (1985) 0.89
Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen. J Exp Med (1983) 0.87
Cellular interactions in the lysis of varicella-zoster virus infected human fibroblasts. Clin Exp Immunol (1986) 0.81
Association of HLA Compatibility and Decreased Liver Transplant Survival. Transplant Proc (1988) 0.81
Human immune responses to herpes simplex virus, varicella-zoster and cytomegalovirus in vitro. Immunology (1986) 0.81
Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes. Clin Exp Immunol (1985) 0.80
Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation. Clin Exp Immunol (1992) 0.79
Parainfluenza type 1 virus-infected cells are killed by both CD8+ and CD4+ cytotoxic T cell precursors. Clin Exp Immunol (1993) 0.79
Blastogenic response of human lymphocytes to early antigen(s) of human cytomegalovirus. Infect Immun (1983) 0.77
Genetic restriction of cytolysis during equid herpesvirus 1 subtype 2 infection. Clin Exp Immunol (1987) 0.77
Effects of interferons and interleukin 2 on natural killing of cytomegalovirus-infected fibroblasts. Clin Exp Immunol (1987) 0.77
Bone marrow transplantation: current results in leukemia. Yale J Biol Med (1983) 0.75
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med (1991) 12.09
Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med (1983) 10.09
NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med (1984) 6.45
Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med (1982) 5.72
Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother (1980) 4.53
Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med (1997) 3.44
Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol (1986) 3.29
Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother (1993) 3.25
Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med (1981) 3.19
Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med (1979) 2.71
Death in the AIDS patient: role of cytomegalovirus. N Engl J Med (1983) 2.61
Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med (1986) 2.47
Symposium on immunosuppressive drugs. Immunosuppressive drugs. I. Fed Proc (1967) 2.44
Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy. Ann Intern Med (1988) 2.42
Venoocclusive disease of the liver following bone marrow transplantation. Transplantation (1987) 2.35
Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest (1983) 2.32
Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. Arch Intern Med (1988) 2.30
Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy. Lancet (1982) 2.28
Herpesvirus infections in the acquired immune deficiency syndrome. JAMA (1984) 2.25
Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med (1988) 2.19
The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis (1980) 2.10
Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl phosphotriester, methylphosphonate and phosphorothioate linkages. Nucleic Acids Res (1987) 2.06
Lichenoid chronic graft-vs-host disease occurring in a dermatomal distribution. Arch Dermatol (1994) 2.05
Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. J Am Acad Dermatol (1996) 2.03
Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus. Ann Intern Med (1984) 2.01
Use of cyclosporin A in allogeneic bone marrow transplantation in the rat. Nature (1979) 1.90
Cytotoxic T lymphocyte response to murine cytomegalovirus infection. Nature (1978) 1.89
Fc receptors induced by herpes simplex virus. I. Biologic and biochemical properties. J Immunol (1978) 1.85
Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii. Ann Intern Med (1985) 1.84
Increased incidence of fungemia caused by Candida krusei. J Clin Microbiol (1986) 1.82
Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1987) 1.82
Summary of clinical trials of inactivated influenza vaccine - 1978. Rev Infect Dis (1983) 1.79
The graft versus host reaction in man after bone marrow transplantation: pathology, pathogenesis, clinical features, and implication. Clin Immunol Immunopathol (1973) 1.78
Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med (1983) 1.75
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci U S A (1996) 1.75
Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. J Immunol (1987) 1.74
Treatment of intraocular inflammatory disease with cyclosporin A. Lancet (1983) 1.74
Preparation and characterization of human HIV type 1 neutralizing reference sera. AIDS Res Hum Retroviruses (1995) 1.73
The impact of a computerized medical record summary system on incidence and length of hospitalization. Med Care (1979) 1.71
Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity. J Am Acad Dermatol (2001) 1.70
Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis (1983) 1.69
Theta-sensitive cell and erythropoiesis: identification of a defect in W/Wv anemic mice. Science (1977) 1.67
Cyclosporin A and the thymus. Immunopathology. Am J Pathol (1987) 1.65
Infectious gastroenteritis in bone-marrow-transplant recipients. N Engl J Med (1982) 1.64
Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia. Am J Med (1986) 1.64
Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. Rev Infect Dis (1983) 1.64
Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols: a clinical-pathologic study of 33 patients. Cancer (1978) 1.63
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol (1989) 1.57
The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol (1994) 1.51
The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection. J Exp Med (1979) 1.51
The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol (1983) 1.51
Vanishing bile duct syndrome in a patient with advanced AIDS. HIV Med (2007) 1.50
Ocular manifestations of graft-vs-host disease. Ophthalmology (1983) 1.50
Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus. J Infect Dis (1988) 1.49
Immunosuppressive drugs. Pharmacol Rev (1970) 1.48
Public Health Service study of Reye's syndrome and medications. Report of the main study. JAMA (1987) 1.47
Esophageal disease in AIDS is associated with pathologic processes rather than mucosal human immunodeficiency virus type 1. J Infect Dis (1993) 1.45
BK and JC virus infections in recipients of bone marrow transplants. J Infect Dis (1988) 1.45
Suppression of thyrotropin in the low-thyroxine state of severe nonthyroidal illness. N Engl J Med (1985) 1.44
Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins. J Virol (2000) 1.43
IL-12 synthesis by human Langerhans cells. J Immunol (1996) 1.43
The semiautonomous replicon: a molecular model for the oncogenicity of SV40. Cold Spring Harb Symp Quant Biol (1975) 1.42
Effect of cyclosporin A on human lymphocyte responses in vitro. II. Induction of specific alloantigen unresponsiveness mediated by a nylon wool adherent suppressor cell. J Immunol (1981) 1.41
Association of busulfan area under the curve with veno-occlusive disease following BMT. Bone Marrow Transplant (1996) 1.41
Evaluation of merocyanine 540-sensitized photoirradiation as a means to inactivate enveloped viruses in blood products. J Lab Clin Med (1990) 1.41
Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med (1983) 1.41
Prolonged survival and remyelination after hematopoietic cell transplantation in the twitcher mouse. Science (1984) 1.39